Blueprint Medicines Added to Russell 2000®, 3000® and Global Indexes
The
About
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/blueprint-medicines-added-to-russell-2000-3000-and-global-indexes-300105819.html
SOURCE
Investor Relations: Beth DelGiacco, Stern Investor Relations, Inc., 212-362-1200, beth@sternir.com or Media: Beth Keshishian, inVentiv Health PR, 212-229-8417, beth.keshishian@inventivhealth.com